SCHEMBL4750227

SCHEMBL4750227

Cc1c(N2C[C@H]3C(F)(F)CC[C@@]3(N)C2)c(F)cc2c(=O)c(C(=O)O)cn([C@@H]3C[C@@H]3F)c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 6/20 0.50
CYP3A4 P08684 1/20 0.46
ALDH1A1 P00352 4/20 0.42
POLB P06746 3/20 0.42
OPRM1 P35372 2/20 0.42
CHRM2 P08172 1/20 0.42
CHRM1 P11229 1/20 0.42
OPRD1 P41143 1/20 0.42
KDM4E B2RXH2 5/20 0.41
KMT2A Q03164 1/20 0.41
SCN5A Q14524 1/20 0.40
AADAT Q8N5Z0 2/20 0.40
LMNA P02545 1/20 0.39
HPGD P15428 3/20 0.39
HSD17B10 Q99714 3/20 0.39
ALB P02768 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2670634 0.90 CYP3A4 (0.55) KCNH2CYP3A4ALDH1A1POLBOPRM1
SCHEMBL4677287 0.86 KCNH2 (0.53) KCNH2CYP3A4ALDH1A1POLBOPRM1
SCHEMBL3977916 0.84 KCNH2 (0.56) KCNH2CYP3A4ALDH1A1POLBOPRM1
SCHEMBL15726080 0.84 KCNH2 (0.51) KCNH2CYP3A4ALDH1A1POLBOPRM1
SCHEMBL14343329 0.84 KCNH2 (0.51) KCNH2CYP3A4ALDH1A1POLBOPRM1
SCHEMBL2670333 0.84 KCNH2 (0.51) KCNH2CYP3A4ALDH1A1POLBOPRM1
SCHEMBL4261553 0.84 KCNH2 (0.54) KCNH2CYP3A4ALDH1A1POLBOPRM1
SCHEMBL14308969 0.84 KCNH2 (0.54) KCNH2CYP3A4ALDH1A1POLBOPRM1
SCHEMBL3978335 0.83 KCNH2 (0.53) KCNH2CYP3A4ALDH1A1POLBOPRM1
SCHEMBL15090879 0.83 KCNH2 (0.53) KCNH2CYP3A4ALDH1A1POLBOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140142096-A1 Fused Substituted Aminopyrrolidine Derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-05-22 US disclosed
US-20140142096-A1 Fused Substituted Aminopyrrolidine Derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-05-22 US disclosed
US-20130029977-A9 Fused substituted aminopyrrolidine derivative DAIICHI SANKYO COMPANY, LIMITED 2013-01-31 US disclosed
US-20130029977-A9 Fused substituted aminopyrrolidine derivative DAIICHI SANKYO COMPANY, LIMITED 2013-01-31 US disclosed
US-20120108582-A1 Fused substituted aminopyrrolidine derivative DAIICHI SANKYO COMPANY, LIMITED 2012-05-03 US disclosed
US-20120108582-A1 Fused substituted aminopyrrolidine derivative DAIICHI SANKYO COMPANY, LIMITED 2012-05-03 US disclosed
WO-2008082009-A2 FUSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-07-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108582-A1 Fused substituted aminopyrrolidine derivative NQO2, QDPR, IL4I1 KCNH2 193/4885CYP3A4 153/4885ALDH1A1 2730/4885
US-20140142096-A1 Fused Substituted Aminopyrrolidine Derivative NQO2, QDPR, IL4I1 KCNH2 193/4885CYP3A4 153/4885ALDH1A1 2730/4885
US-20130029977-A9 Fused substituted aminopyrrolidine derivative NQO2, QDPR, IL4I1 KCNH2 193/4885CYP3A4 153/4885ALDH1A1 2730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.